Carregant...
Endothelial Dysfunction in the Smokers Can Be Improved with Oral Cilostazol Treatment
BACKGROUND: Smoking is one of well known environmental factors causing endothelial dysfunction and plays important role in the atherosclerosis. We investigated the effect of cilostazol could improve the endothelial dysfunction in smokers with the measurement of flow-mediated dilatation (FMD). METHOD...
Guardat en:
| Autors principals: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Korean Society of Echocardiography
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3079080/ https://ncbi.nlm.nih.gov/pubmed/21519488 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4250/jcu.2011.19.1.21 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|